US Hemp Roundtable’s 365-Day Mission: A Regulatory Framework Instead of a Total Ban

When the Agricultural Appropriations Act passed in November 2025 with its hemp redefinition and November 12, 2026 compliance deadline embedded in it, the US Hemp Roundtable — the industry’s primary trade and advocacy organization — responded with a clear-eyed assessment: disappointed, but not defeated. The 365-day window before the law’s effective date, the Roundtable announced, would be used to demonstrate to Congress and federal regulators that the hemp industry can and should be regulated, not banned.

Six months into that mission, the Roundtable’s strategy has taken shape around a specific proposal: a robust regulatory framework for hemp-derived cannabinoid products that replaces the total ban with structured oversight. Understanding what that framework looks like, who is advancing it, and what its chances are is essential context for any hemp brand thinking beyond November 12.

The Problem With a Total Ban, According to the Roundtable

The US Hemp Roundtable’s core argument against the November 12 total ban approach is straightforward: a ban on hemp-derived cannabinoid products that meet total THC limits is not a proportionate regulatory response to the legitimate problems in the market — synthetic cannabinoids, age accessibility, label inaccuracy, and unregulated potency. Banning an entire product category doesn’t solve these problems; it eliminates the legal market while pushing consumers toward unregulated alternatives.

The Roundtable estimates that the ban would eliminate approximately 95% of existing hemp-derived cannabinoid products, eliminate more than 300,000 jobs, and cost state governments over $1.5 billion in aggregate tax revenue. They argue that these losses are not justified when the regulatory problems driving the ban — synthetic cannabinoids, high-potency products targeting children, label inaccuracy — can be addressed through targeted regulation rather than categorical prohibition.

What the Roundtable’s Regulatory Framework Proposes

The alternative framework the US Hemp Roundtable is advancing, championed in the House by Representative Morgan Griffith (R-VA) and supported by trade groups across the hemp industry, includes several core components:

Good Manufacturing Practices (GMP) compliance. Rather than banning products, require that all hemp-derived cannabinoid products be manufactured to GMP standards — the same framework applied to dietary supplements and food additives. GMP compliance requires documented manufacturing processes, quality control systems, and facility standards that create accountability without eliminating the product category.

Truth in labeling requirements. Mandatory, accurate labeling of cannabinoid content, including total THC using the federal calculation formula. Labels must match COA results, and COAs must come from accredited laboratories. This addresses one of the most common consumer protection concerns about the hemp market without requiring a ban.

Prohibition on synthetic cannabinoids. A targeted ban on cannabinoids that don’t naturally occur in the hemp plant — THC-O, synthetic delta-8, THCP manufactured in laboratories. This addresses the chemical category that generates the most legitimate safety concerns without eliminating products derived from naturally occurring cannabinoids.

Age restriction enforcement. Federal minimum age requirements for the purchase of hemp-derived cannabinoid products, with mechanisms for state enforcement. This addresses the most legitimate consumer protection concern (access by minors) directly.

Federal product registry or notification. A system by which hemp-derived cannabinoid products are registered or notified with a federal agency before commercial sale, creating a marketplace accountability mechanism without requiring pre-market approval.

How This Framework Compares to Current Law

The framework the Roundtable is proposing is substantively different from both the current total ban and the Hemp Safety Enforcement Act’s state opt-out approach:

Vs. total ban: The Roundtable framework preserves a legal national market for hemp-derived cannabinoid products that meet safety standards. The total ban eliminates the market nationally (except in opt-out states under the Paul/Klobuchar/Ernst bill).

Vs. the state opt-out approach: The Roundtable framework would create a national regulatory standard rather than a patchwork of state-level standards. It would also provide the federal regulatory infrastructure (GMP, labeling, registration) that the opt-out approach largely delegates to states.

Vs. the status quo: The Roundtable framework is more stringent than the pre-2026 regulatory environment. GMP requirements, mandatory labeling accuracy, and a synthetic cannabinoid prohibition all represent new obligations on the hemp industry — obligations the Roundtable is willing to accept as the price of maintaining a legal national market.

How Realistic Is This Framework?

The regulatory framework approach has significant industry support and bipartisan legislative backing in the House through Rep. Griffith’s proposed legislation. However, its path to becoming law faces the same challenges as any hemp-related legislative effort:

Timeline pressure. The Farm Bill conference process between the House and Senate must conclude, and any hemp regulatory framework must either be incorporated into Farm Bill language or advanced as standalone legislation — all before November 12. That is an aggressive timeline.

Political headwinds. The administration’s ONDCP strategy and legal authority claims signal that the White House is not inclined toward a permissive regulatory framework for hemp-derived cannabinoids. A Griffith-style regulatory approach would need enough congressional support to overcome or redirect executive branch resistance.

Industry credibility challenge. The Roundtable’s argument that the hemp industry should be regulated rather than banned requires demonstrating that the industry can meet the regulatory standards it’s proposing. GMP compliance and label accuracy have not been uniform in the hemp market — that history is part of why the ban passed in the first place.

LGH Perspective

Low Gravity Hemp is exactly the kind of operator the US Hemp Roundtable’s regulatory framework is designed to protect and recognize — a B2B ingredient supplier operating with GMP-consistent practices, accurate labeling, accredited laboratory testing, and natural (non-synthetic) cannabinoid profiles. If a regulatory framework replaces the total ban, we’re positioned to meet its requirements on day one. If the ban takes full effect, we’re positioned to supply the compliant products that remain legal. Our supply model is built to win in either regulatory scenario.

Final Thoughts

The US Hemp Roundtable’s 365-day mission is a serious, substantive advocacy campaign backed by industry data, legislative allies, and a credible alternative framework. Whether it succeeds depends on factors — Senate Farm Bill negotiations, White House posture, congressional timeline — that are not fully in the industry’s control.

What the Roundtable’s framework makes clear is what the baseline for a “regulated hemp market” would look like: GMP compliance, accurate labeling, no synthetics, age restrictions. Any hemp brand that can’t meet those requirements isn’t in the conversation for a sustainable legal future in any regulatory scenario.

Ready to discuss what a regulatory-framework-ready hemp supply chain looks like? Contact Low Gravity Hemp to talk about GMP-consistent ingredient sourcing, accurate COA documentation, and natural cannabinoid supply chains built for any outcome.